Back
Kaival Brands Innovations Group Vs. Regencell Bioscience Holdings Industry Stock Comparison
Sell
20
KAVL
Kaival Brands Innovations Group
Last Price:
$0.56
Seasonality Move:
686.17%
Buy
52
RGC
Regencell Bioscience Holdings
Last Price:
$31.39
Seasonality Move:
7.47%
Sell
20
Kaival Brands Innovations Group (KAVL)
is a Sell
Is Kaival Brands Innovations Group a Buy, Sell or Hold?
-
The current Kaival Brands Innovations Group [KAVL] share price is $0.61. The Score for KAVL is 20, which is 60% below its historic median score of 50, and infers higher risk than normal.
-
KAVL is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing an extreme reading that indicates risk could be especially high.
Buy
52
Regencell Bioscience Holdings (RGC)
is a Buy
Is Regencell Bioscience Holdings a Buy, Sell or Hold?
-
The current Regencell Bioscience Holdings [RGC] share price is $31.60. The Score for RGC is 52, which is 4% above its historic median score of 50, and infers lower risk than normal.
-
RGC is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
KAVL Stock Price Chart
What is Kaival Brands Innovations Group's stock price today?
-
The Kaival Brands Innovations Group share price today is $0.61Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and KAVL is experiencing slight buying pressure.
RGC Stock Price Chart
What is Regencell Bioscience Holdings's stock price today?
-
The Regencell Bioscience Holdings share price today is $31.60Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and RGC is experiencing buying pressure, which is a positive indicator for future bullish movement.
KAVL Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.13 | Sell |
Relative Strength Index (14 RSI): | 28.92 | Sell |
Chaikin Money Flow: | 23379 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (0.64 - 1.14) | Sell |
Bollinger Bands (100): | (0.73 - 1.15) | Sell |
RGC Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 3.77 | Buy |
Relative Strength Index (14 RSI): | 92.95 | Buy |
Chaikin Money Flow: | 2932579 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (0.28 - 12.84) | Buy |
Bollinger Bands (100): | (2.4 - 9) | Buy |
KAVL Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 0.66 | Sell |
20-day SMA: | 0.78 | Sell |
50-day SMA: | 1.02 | Sell |
200-day SMA: | 1.06 | Sell |
8-day EMA: | 0.66 | Sell |
20-day EMA: | 0.79 | Sell |
50-day EMA: | 0.92 | Sell |
200-day EMA: | 1.66 | Sell |
RGC Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 11.67 | Buy |
20-day SMA: | 7.28 | Buy |
50-day SMA: | 5.54 | Buy |
200-day SMA: | 5.93 | Buy |
8-day EMA: | 14.93 | Buy |
20-day EMA: | 9.42 | Buy |
50-day EMA: | 6.7 | Buy |
200-day EMA: | 6.49 | Buy |
Kaival Brands Innovations Group Earnings Growth & KAVL Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Regencell Bioscience Holdings Earnings Growth & RGC Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Kaival Brands Innovations Group Technical Analysis
Mar 4 | Mar 5 | Mar 6 | Mar 7 | Mar 11 | Mar 12 | Mar 13 | Mar 14 | Mar 17 | Mar 18 | |
---|---|---|---|---|---|---|---|---|---|---|
Mar | ||||||||||
04 | 05 | 06 | 07 | 11 | 12 | 13 | 14 | 17 | 18 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Regencell Bioscience Holdings Technical Analysis
Mar 4 | Mar 5 | Mar 6 | Mar 7 | Mar 11 | Mar 12 | Mar 13 | Mar 14 | Mar 17 | Mar 18 | |
---|---|---|---|---|---|---|---|---|---|---|
Mar | ||||||||||
04 | 05 | 06 | 07 | 11 | 12 | 13 | 14 | 17 | 18 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |